ArticlePloS one2014

Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome.

Jose Ramón Vidal-Castiñeira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.